PIONIERKRAFT raises a high seven-figure amount in Series A financing round from climate tech investor First Imagine!
22.10.2024 08:46:54 CEST | news aktuell GmbH | Press release
Munich, 21 October 2024
Munich-based energy start-up PIONIERKRAFT has raised a high seven-figure amount in its Series A financing round, led by First Imagine!, a European venture capital firm focused on innovative solutions for a sustainable future. With this investment, PIONIERKRAFT will expand its energy-sharing solution for apartment buildings.
"When we founded PIONIERKRAFT in 2019, we saw an opportunity to build a foundation for the energy transition in small and medium-sized apartment buildings," says Andreas Eberhardt, CEO of PIONIERKRAFT. "This funding will help us scale our network of partners and ramp up mass production of our energy-sharing solution."
First Imagine! recognizes PIONIERKRAFT's growth potential and aims to accelerate the renewable energy transition. "Partnering with PIONIERKRAFT allows us to address the large sector of multi-tenant buildings in Germany that has been excluded from rooftop solar installations," says Alexander Starchenko, Managing Partner of First Imagine!.
The financing will also support the launch of PIONIERKRAFTwerk 3.0, setting new benchmarks in performance and ease of use, making the solution even more compelling to landlords and encouraging the decarbonization of Germany's apartment buildings.
PIONIERKRAFT has also welcomed Hartmut Michels, CEO of standata GmbH, to its advisory board. Michels' experience in the housing and energy sector will support the company’s growth and rollout of PIONIERKRAFTwerk. "The PIONIERKRAFTwerk is a big step towards the Home Energy Management System," Michels notes.
The Series A financing round was supported by Quantum Partners, an M&A consultancy based in Munich specializing in corporate finance and growth capital.
Press Contact
PIONIERKRAFT GmbH
Agnes-Pockels-Bogen 1
80992 Munich
Daniela Schwendy
presse@pionierkraft.de
www.pionierkraft.de
Maisberger GmbH
Jennifer Appel/Julia Kirchhoff
Telefon: +49 (0)89 / 41 95 99-77, -55
E-Mail: pionierkraft@maisberger.com
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Acrobat Studio og Acrobat KI-assistent: den nye generasjonen KI-støttet produktivitet – nå også på norsk8.7.2026 15:08:48 CEST | Press release
SAN JOSE, Calif. - 8. juli 2026 - Adobe utvider tilgjengeligheten til Acrobat Studio og Acrobat KI-assistenten i Norge. Nå er de KI-støttede funksjonene for produktivitet og kreavtivitet også tilgjengelige på norsk, og kan dermed brukes av brukere på lokalt språk. Acrobat Studio kombinerer Adobe Acrobat Pro, Adobe Express Premium og smarte KI-assistenter. Acrobat KI-assistent er også tilgjengelig som et separat tillegg for alle Adobe Acrobat-produkter (Acrobat Reader, Acrobat Standard og Acrobat Pro) – et fleksibelt alternativ for alle som ønsker å bruke KI-støttede funksjoner kun når de arbeider med dokumenter. Begge disse tilbudene gjør det mulig for brukere å raskere samle inn informasjon i PDF-er og Office-dokumenter, opprette innhold og effektivisere arbeidsflyten. Acrobat Studio og Acrobat KI-assistenten markerer et viktig trinn i utviklingen av PDF-filen, som har blitt standarden for viktige dokumenter siden den ble lansert av Adobe i 1993. Acrobat utvikler seg fra et ledende pr
Grünenthal receives FDA Orphan Drug and Rare Pediatric Disease Designations for Tegacorat for the Treatment of Duchenne Muscular Dystrophy8.7.2026 10:37:04 CEST | Press release
Aachen, 08 July 2026 – Grünenthal announced today that its investigational compound tegacorat (GRM-01) received Orphan Drug and Rare Pediatric Disease Designations from the US Food and Drug Administration (FDA) for the treatment of Duchenne muscular dystrophy (DMD).
Grünenthal successfully completes Phase I trial with Nociceptin Receptor (NOP) Agonist29.6.2026 12:28:23 CEST | Press release
The investigational compound has a unique mechanism of action and the potential to become a first-in-class therapy option for the treatment of acute and chronic pain. In a Phase I trial, the investigational compound was demonstrated to be safe and well tolerated. A Phase II trial will commence later this year.
FRITZ: YouGov survey in 14 countries: Trust in router manufacturers from different regions European consumers mistrust Chinese routers29.6.2026 10:00:00 CEST | Press release
More than half of consumers in Norway mistrust routers from Chinese manufacturers (59%) Many mistrust devices made in the USA European routers enjoy a high level of trust across Europe (60%) For half of Europeans (55%), the ‘Made in Europe’ label important to when making a purchase
93% of Europe's Internet Traffic Flows Through Routers – Yet No One Is Paying Attention: Study Demands Action on Digital Sovereignty24.6.2026 10:00:00 CEST | Press release
Berlin, 24 June 2026 – The Sovereignty Alliance for European Network Technology (SAFENet), together with the Innovate Europe Foundation (IE.F) and Berlin-based consultancy iconomy, publishes a new foundational study revealing that 93% of European internet traffic flows through routers and yet the EU has no sovereignty framework for this key component of the digital ecosystem. Meanwhile, Chinese manufacturers already control 37% of the market.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom